Pathways’ Picks February 24: EU Standards, Mutation Monitoring, CDRH Staff Moves, and More

article image

In this week’s roundup: EU policymakers are optimistic about picking up the pace in aligning standards with the MDR; FDA takes steps to address COVID-19 mutations in diagnostics; a roundup of personnel exits and appointments at FDA’s device center, CMS, and AdvaMed; a global check-in, including Australia and Canada news, and more to watch.

Following a serious setback last year in efforts to formally link consensus technical device standards with compliance to the oncoming EU Medical Device and IVD Regulations, European policymakers are optimistic they can achieve a course correction by this spring, before MDR fully applies in May. That news leads off the latest edition of Pathways’ Picks.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: